Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men

(2017) A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men. Pharmaceutical Biology. pp. 1800-1805. ISSN 1388-0209

[img] Text
A two-week, double-blind, placebo-controlled trial of viola odorata, echium amoenum and physalis alkekengi mixture in symptomatic benign prostate hyperplasia (Bph) men.pdf

Download (948kB)

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet. Objective: This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients. Materials and methods: Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm(3) were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5 respectively) (treatment group). Results: IPSS score of incomplete urination (42.3 +/- 2.04), frequency of urination (20.08 +/- 1.02), intermittency (40.78 +/- 2.16), urgency (60.91 +/- 3.14), weak stream (50.58 +/- 2.14), straining (55.67 +/- 2.53) and nocturia (40.14 +/- 1.89) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 +/- 0.89) and extant urine volume (28.12 +/- 1.36) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study. Discussion and conclusions: Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH.

Item Type: Article
Keywords: IPSS score quality of life prostate volume extant urine volume urinary-tract symptoms clinical-trial depressive symptoms beta-sitosterol 5-alpha-reductase inflammation dihydrotestosterone dutasteride inhibitors extract Plant Sciences Medical Laboratory Technology Pharmacology & Pharmacy
Divisions:
Page Range: pp. 1800-1805
Journal or Publication Title: Pharmaceutical Biology
Journal Index: ISI
Volume: 55
Number: 1
Identification Number: https://doi.org/10.1080/13880209.2017.1328445
ISSN: 1388-0209
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/4419

Actions (login required)

View Item View Item